BRCA1 and BRCA2 testing for Ovarian Cancer

Ultima Vez Modificado: 17 de octubre del 2003

Share article


Question

Dear OncoLink "Ask The Experts,"
My mother had ovarian cancer at the age of 50, I am now 49 and of Jewish heritage. It seems that the genetic testing is no longer easily accessible. How would I go about getting genetic testing? 

Answer

Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:

About 10% of all ovarian cancers occur as a result of an inherited condition mostly related to abnormalities in the BRCA1 and BRCA2 genes, which also increase the risk of breast cancer. You may indeed be a candidate for genetic testing, which is done by Myriad Genetics in Utah. This can be arranged through many doctors' offices or through cancer risk evaluation programs, such as the one we have here at the University of Pennsylvania.


News
Germ-Line BRCA1/2 Testing Recommended in Ovarian Cancer

Jun 20, 2012 - Due to the potential survival and treatment response implications of BRCA mutation status, it is recommended that germ-line BRCA1/2 testing be offered to all women diagnosed with nonmucinous ovarian carcinoma, regardless of family history, according to research published online June 18 in the Journal of Clinical Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información